- Home
- SCYX vs ZCMD Comparison
SCYX vs ZCMD Comparison
Compare SCYX & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- ZCMD
- Stock Information
- Founded
- SCYX 1999
- ZCMD 2012
- Country
- SCYX United States
- ZCMD China
- Employees
- SCYX N/A
- ZCMD N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- SCYX Health Care
- ZCMD Real Estate
- Exchange
- SCYX Nasdaq
- ZCMD Nasdaq
- Market Cap
- SCYX 28.5M
- ZCMD 29.0M
- IPO Year
- SCYX 2014
- ZCMD 2020
- Fundamental
- Price
- SCYX $0.70
- ZCMD $1.18
- Analyst Decision
- SCYX
- ZCMD
- Analyst Count
- SCYX 0
- ZCMD 0
- Target Price
- SCYX N/A
- ZCMD N/A
- AVG Volume (30 Days)
- SCYX 127.6K
- ZCMD 658.1K
- Earning Date
- SCYX 08-07-2025
- ZCMD 01-01-0001
- Dividend Yield
- SCYX N/A
- ZCMD N/A
- EPS Growth
- SCYX N/A
- ZCMD N/A
- EPS
- SCYX N/A
- ZCMD N/A
- Revenue
- SCYX $2,630,000.00
- ZCMD $15,864,773.00
- Revenue This Year
- SCYX $463.61
- ZCMD N/A
- Revenue Next Year
- SCYX $310.80
- ZCMD N/A
- P/E Ratio
- SCYX N/A
- ZCMD N/A
- Revenue Growth
- SCYX N/A
- ZCMD N/A
- 52 Week Low
- SCYX $0.66
- ZCMD $0.95
- 52 Week High
- SCYX $2.29
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- SCYX 40.46
- ZCMD 49.32
- Support Level
- SCYX $0.70
- ZCMD $1.12
- Resistance Level
- SCYX $0.75
- ZCMD $1.24
- Average True Range (ATR)
- SCYX 0.04
- ZCMD 0.13
- MACD
- SCYX 0.00
- ZCMD -0.00
- Stochastic Oscillator
- SCYX 32.29
- ZCMD 26.71
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.